Grace Science
Pre-clinicalBy assembling a world class, multidisciplinary team of experts and encouraging them to share expertise and knowledge, we’ve developed biological insights that suggest why NGLY1 loss leads to disease and how to restore it.
Founded
2017
Focus
RNA & Gene TherapySmall MoleculesViral Technology
About
By assembling a world class, multidisciplinary team of experts and encouraging them to share expertise and knowledge, we’ve developed biological insights that suggest why NGLY1 loss leads to disease and how to restore it.
Funding History
1Total raised: $40M
Series A$40MNovo HoldingsMay 15, 2023
Company Info
TypePrivate
Founded2017
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile